nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepivacaine—SCN10A—breast cancer	0.657	1	CbGaD
Mepivacaine—Bupivacaine—PTGER1—breast cancer	0.00257	0.28	CrCbGaD
Mepivacaine—Levobupivacaine—SCN10A—breast cancer	0.00121	0.132	CrCbGaD
Mepivacaine—Bupivacaine—SCN10A—breast cancer	0.000966	0.106	CrCbGaD
Mepivacaine—Ropivacaine—SCN10A—breast cancer	0.000779	0.085	CrCbGaD
Mepivacaine—Tocainide—SCN10A—breast cancer	0.000732	0.08	CrCbGaD
Mepivacaine—Lidocaine—SCN10A—breast cancer	0.000566	0.0618	CrCbGaD
Mepivacaine—Lidocaine—EGFR—breast cancer	0.000408	0.0446	CrCbGaD
Mepivacaine—Levobupivacaine—CYP3A4—breast cancer	0.000318	0.0348	CrCbGaD
Mepivacaine—Bupivacaine—CYP2D6—breast cancer	0.000297	0.0324	CrCbGaD
Mepivacaine—SCN9A—pituitary gland—breast cancer	0.000288	0.0732	CbGeAlD
Mepivacaine—SCN9A—adipose tissue—breast cancer	0.000287	0.0729	CbGeAlD
Mepivacaine—SCN9A—adrenal gland—breast cancer	0.000257	0.0654	CbGeAlD
Mepivacaine—SCN4A—pituitary gland—breast cancer	0.000257	0.0653	CbGeAlD
Mepivacaine—SCN4A—adipose tissue—breast cancer	0.000256	0.0651	CbGeAlD
Mepivacaine—Bupivacaine—CYP3A4—breast cancer	0.000255	0.0278	CrCbGaD
Mepivacaine—SCN8A—endocrine gland—breast cancer	0.000254	0.0646	CbGeAlD
Mepivacaine—Ropivacaine—CYP2D6—breast cancer	0.000239	0.0261	CrCbGaD
Mepivacaine—Anaphylactic shock—Gemcitabine—breast cancer	0.000234	0.00123	CcSEcCtD
Mepivacaine—Oedema—Gemcitabine—breast cancer	0.000234	0.00123	CcSEcCtD
Mepivacaine—Asthenia—Goserelin—breast cancer	0.000233	0.00122	CcSEcCtD
Mepivacaine—Nervousness—Paclitaxel—breast cancer	0.000233	0.00122	CcSEcCtD
Mepivacaine—Hyperhidrosis—Mitoxantrone—breast cancer	0.000232	0.00122	CcSEcCtD
Mepivacaine—Hyperhidrosis—Irinotecan—breast cancer	0.000232	0.00122	CcSEcCtD
Mepivacaine—Back pain—Paclitaxel—breast cancer	0.000232	0.00122	CcSEcCtD
Mepivacaine—Dizziness—Vinblastine—breast cancer	0.000231	0.00122	CcSEcCtD
Mepivacaine—Urticaria—Vinorelbine—breast cancer	0.000231	0.00121	CcSEcCtD
Mepivacaine—Bradycardia—Capecitabine—breast cancer	0.00023	0.00121	CcSEcCtD
Mepivacaine—Body temperature increased—Vinorelbine—breast cancer	0.00023	0.00121	CcSEcCtD
Mepivacaine—Pruritus—Goserelin—breast cancer	0.00023	0.00121	CcSEcCtD
Mepivacaine—Anaphylactic shock—Fluorouracil—breast cancer	0.00023	0.00121	CcSEcCtD
Mepivacaine—Oedema—Fluorouracil—breast cancer	0.00023	0.00121	CcSEcCtD
Mepivacaine—SCN4A—adrenal gland—breast cancer	0.000229	0.0584	CbGeAlD
Mepivacaine—SCN2A—pituitary gland—breast cancer	0.000227	0.0578	CbGeAlD
Mepivacaine—Nausea—Chlorambucil—breast cancer	0.000227	0.00119	CcSEcCtD
Mepivacaine—Vision blurred—Paclitaxel—breast cancer	0.000226	0.00119	CcSEcCtD
Mepivacaine—Hyperhidrosis—Gemcitabine—breast cancer	0.000226	0.00119	CcSEcCtD
Mepivacaine—Dizziness—Tamoxifen—breast cancer	0.000225	0.00118	CcSEcCtD
Mepivacaine—Tremor—Paclitaxel—breast cancer	0.000225	0.00118	CcSEcCtD
Mepivacaine—Tachycardia—Fluorouracil—breast cancer	0.000224	0.00118	CcSEcCtD
Mepivacaine—Hypotension—Irinotecan—breast cancer	0.000224	0.00118	CcSEcCtD
Mepivacaine—Hypotension—Mitoxantrone—breast cancer	0.000224	0.00118	CcSEcCtD
Mepivacaine—Vomiting—Vinblastine—breast cancer	0.000223	0.00117	CcSEcCtD
Mepivacaine—Urticaria—Thiotepa—breast cancer	0.000221	0.00116	CcSEcCtD
Mepivacaine—Agitation—Paclitaxel—breast cancer	0.00022	0.00116	CcSEcCtD
Mepivacaine—Body temperature increased—Thiotepa—breast cancer	0.00022	0.00115	CcSEcCtD
Mepivacaine—Headache—Vinblastine—breast cancer	0.000219	0.00115	CcSEcCtD
Mepivacaine—SCN10A—pituitary gland—breast cancer	0.000219	0.0558	CbGeAlD
Mepivacaine—Angioedema—Paclitaxel—breast cancer	0.000219	0.00115	CcSEcCtD
Mepivacaine—Hypotension—Gemcitabine—breast cancer	0.000218	0.00115	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Doxorubicin—breast cancer	0.000218	0.00114	CcSEcCtD
Mepivacaine—Cardiac arrest—Epirubicin—breast cancer	0.000216	0.00114	CcSEcCtD
Mepivacaine—Vomiting—Tamoxifen—breast cancer	0.000216	0.00114	CcSEcCtD
Mepivacaine—Paraesthesia—Irinotecan—breast cancer	0.000215	0.00113	CcSEcCtD
Mepivacaine—Paraesthesia—Mitoxantrone—breast cancer	0.000215	0.00113	CcSEcCtD
Mepivacaine—Syncope—Paclitaxel—breast cancer	0.000215	0.00113	CcSEcCtD
Mepivacaine—Dizziness—Goserelin—breast cancer	0.000215	0.00113	CcSEcCtD
Mepivacaine—Hypotension—Fluorouracil—breast cancer	0.000215	0.00113	CcSEcCtD
Mepivacaine—Hypersensitivity—Vinorelbine—breast cancer	0.000214	0.00113	CcSEcCtD
Mepivacaine—Somnolence—Mitoxantrone—breast cancer	0.000213	0.00112	CcSEcCtD
Mepivacaine—Somnolence—Irinotecan—breast cancer	0.000213	0.00112	CcSEcCtD
Mepivacaine—Headache—Tamoxifen—breast cancer	0.000213	0.00112	CcSEcCtD
Mepivacaine—Vomiting—Melphalan—breast cancer	0.000212	0.00111	CcSEcCtD
Mepivacaine—Tinnitus—Capecitabine—breast cancer	0.000211	0.00111	CcSEcCtD
Mepivacaine—Loss of consciousness—Paclitaxel—breast cancer	0.000211	0.00111	CcSEcCtD
Mepivacaine—Paraesthesia—Gemcitabine—breast cancer	0.00021	0.0011	CcSEcCtD
Mepivacaine—Chills—Docetaxel—breast cancer	0.000209	0.0011	CcSEcCtD
Mepivacaine—Asthenia—Vinorelbine—breast cancer	0.000209	0.0011	CcSEcCtD
Mepivacaine—Nausea—Vinblastine—breast cancer	0.000208	0.00109	CcSEcCtD
Mepivacaine—Somnolence—Gemcitabine—breast cancer	0.000208	0.00109	CcSEcCtD
Mepivacaine—Convulsion—Paclitaxel—breast cancer	0.000208	0.00109	CcSEcCtD
Mepivacaine—Hypertension—Paclitaxel—breast cancer	0.000207	0.00109	CcSEcCtD
Mepivacaine—Vomiting—Goserelin—breast cancer	0.000207	0.00109	CcSEcCtD
Mepivacaine—Paraesthesia—Fluorouracil—breast cancer	0.000206	0.00108	CcSEcCtD
Mepivacaine—Pruritus—Vinorelbine—breast cancer	0.000206	0.00108	CcSEcCtD
Mepivacaine—Ropivacaine—CYP3A4—breast cancer	0.000205	0.0224	CrCbGaD
Mepivacaine—Hypersensitivity—Thiotepa—breast cancer	0.000205	0.00108	CcSEcCtD
Mepivacaine—Somnolence—Fluorouracil—breast cancer	0.000204	0.00107	CcSEcCtD
Mepivacaine—Headache—Goserelin—breast cancer	0.000203	0.00107	CcSEcCtD
Mepivacaine—Anxiety—Paclitaxel—breast cancer	0.000203	0.00107	CcSEcCtD
Mepivacaine—Erythema—Docetaxel—breast cancer	0.000203	0.00107	CcSEcCtD
Mepivacaine—Chills—Capecitabine—breast cancer	0.000203	0.00107	CcSEcCtD
Mepivacaine—Nausea—Tamoxifen—breast cancer	0.000202	0.00106	CcSEcCtD
Mepivacaine—Cardiac arrest—Doxorubicin—breast cancer	0.0002	0.00105	CcSEcCtD
Mepivacaine—SCN3A—pituitary gland—breast cancer	0.0002	0.0508	CbGeAlD
Mepivacaine—Asthenia—Thiotepa—breast cancer	0.000199	0.00105	CcSEcCtD
Mepivacaine—SCN3A—adipose tissue—breast cancer	0.000199	0.0506	CbGeAlD
Mepivacaine—Nausea—Melphalan—breast cancer	0.000198	0.00104	CcSEcCtD
Mepivacaine—Erythema—Capecitabine—breast cancer	0.000197	0.00103	CcSEcCtD
Mepivacaine—Back pain—Docetaxel—breast cancer	0.000197	0.00103	CcSEcCtD
Mepivacaine—Pruritus—Thiotepa—breast cancer	0.000197	0.00103	CcSEcCtD
Mepivacaine—Anaphylactic shock—Paclitaxel—breast cancer	0.000196	0.00103	CcSEcCtD
Mepivacaine—Oedema—Paclitaxel—breast cancer	0.000196	0.00103	CcSEcCtD
Mepivacaine—Nausea—Goserelin—breast cancer	0.000193	0.00101	CcSEcCtD
Mepivacaine—Shock—Paclitaxel—breast cancer	0.000193	0.00101	CcSEcCtD
Mepivacaine—Dizziness—Vinorelbine—breast cancer	0.000192	0.00101	CcSEcCtD
Mepivacaine—Tachycardia—Paclitaxel—breast cancer	0.000191	0.001	CcSEcCtD
Mepivacaine—Urticaria—Mitoxantrone—breast cancer	0.000191	0.001	CcSEcCtD
Mepivacaine—Back pain—Capecitabine—breast cancer	0.00019	0.001	CcSEcCtD
Mepivacaine—Body temperature increased—Mitoxantrone—breast cancer	0.00019	0.000997	CcSEcCtD
Mepivacaine—Body temperature increased—Irinotecan—breast cancer	0.00019	0.000997	CcSEcCtD
Mepivacaine—Hyperhidrosis—Paclitaxel—breast cancer	0.000189	0.000994	CcSEcCtD
Mepivacaine—Drowsiness—Methotrexate—breast cancer	0.000187	0.000985	CcSEcCtD
Mepivacaine—Vision blurred—Capecitabine—breast cancer	0.000185	0.000974	CcSEcCtD
Mepivacaine—Vomiting—Vinorelbine—breast cancer	0.000185	0.000972	CcSEcCtD
Mepivacaine—Body temperature increased—Gemcitabine—breast cancer	0.000185	0.000971	CcSEcCtD
Mepivacaine—Tremor—Capecitabine—breast cancer	0.000184	0.000969	CcSEcCtD
Mepivacaine—Dizziness—Thiotepa—breast cancer	0.000184	0.000965	CcSEcCtD
Mepivacaine—SCN3A—female reproductive system—breast cancer	0.000183	0.0465	CbGeAlD
Mepivacaine—Hypotension—Paclitaxel—breast cancer	0.000183	0.000961	CcSEcCtD
Mepivacaine—Urticaria—Fluorouracil—breast cancer	0.000183	0.000959	CcSEcCtD
Mepivacaine—Headache—Vinorelbine—breast cancer	0.000182	0.000958	CcSEcCtD
Mepivacaine—Syncope—Docetaxel—breast cancer	0.000182	0.000958	CcSEcCtD
Mepivacaine—Body temperature increased—Fluorouracil—breast cancer	0.000182	0.000954	CcSEcCtD
Mepivacaine—Sweating—Methotrexate—breast cancer	0.00018	0.000944	CcSEcCtD
Mepivacaine—Loss of consciousness—Docetaxel—breast cancer	0.000179	0.000939	CcSEcCtD
Mepivacaine—SCN3A—adrenal gland—breast cancer	0.000178	0.0454	CbGeAlD
Mepivacaine—Hypersensitivity—Mitoxantrone—breast cancer	0.000177	0.000929	CcSEcCtD
Mepivacaine—Hypersensitivity—Irinotecan—breast cancer	0.000177	0.000929	CcSEcCtD
Mepivacaine—Vomiting—Thiotepa—breast cancer	0.000177	0.000928	CcSEcCtD
Mepivacaine—Syncope—Capecitabine—breast cancer	0.000176	0.000927	CcSEcCtD
Mepivacaine—SCN2A—endocrine gland—breast cancer	0.000176	0.0448	CbGeAlD
Mepivacaine—Convulsion—Docetaxel—breast cancer	0.000176	0.000925	CcSEcCtD
Mepivacaine—Paraesthesia—Paclitaxel—breast cancer	0.000176	0.000923	CcSEcCtD
Mepivacaine—Hypertension—Docetaxel—breast cancer	0.000175	0.000922	CcSEcCtD
Mepivacaine—Drowsiness—Epirubicin—breast cancer	0.000175	0.000922	CcSEcCtD
Mepivacaine—Headache—Thiotepa—breast cancer	0.000174	0.000915	CcSEcCtD
Mepivacaine—Somnolence—Paclitaxel—breast cancer	0.000174	0.000914	CcSEcCtD
Mepivacaine—Lidocaine—CYP2D6—breast cancer	0.000174	0.019	CrCbGaD
Mepivacaine—Loss of consciousness—Capecitabine—breast cancer	0.000173	0.000909	CcSEcCtD
Mepivacaine—Nausea—Vinorelbine—breast cancer	0.000173	0.000908	CcSEcCtD
Mepivacaine—SCN3A—bone marrow—breast cancer	0.000173	0.0439	CbGeAlD
Mepivacaine—Asthenia—Mitoxantrone—breast cancer	0.000172	0.000904	CcSEcCtD
Mepivacaine—Asthenia—Irinotecan—breast cancer	0.000172	0.000904	CcSEcCtD
Mepivacaine—Hypertension—Capecitabine—breast cancer	0.00017	0.000893	CcSEcCtD
Mepivacaine—SCN10A—endocrine gland—breast cancer	0.00017	0.0432	CbGeAlD
Mepivacaine—Hypersensitivity—Fluorouracil—breast cancer	0.000169	0.00089	CcSEcCtD
Mepivacaine—Tocainide—ALB—breast cancer	0.000168	0.0184	CrCbGaD
Mepivacaine—Sweating—Epirubicin—breast cancer	0.000168	0.000884	CcSEcCtD
Mepivacaine—Asthenia—Gemcitabine—breast cancer	0.000168	0.000881	CcSEcCtD
Mepivacaine—Anxiety—Capecitabine—breast cancer	0.000167	0.000877	CcSEcCtD
Mepivacaine—Oedema—Docetaxel—breast cancer	0.000166	0.000871	CcSEcCtD
Mepivacaine—Anaphylactic shock—Docetaxel—breast cancer	0.000166	0.000871	CcSEcCtD
Mepivacaine—Pruritus—Gemcitabine—breast cancer	0.000165	0.000869	CcSEcCtD
Mepivacaine—Nausea—Thiotepa—breast cancer	0.000165	0.000867	CcSEcCtD
Mepivacaine—Shock—Docetaxel—breast cancer	0.000163	0.000857	CcSEcCtD
Mepivacaine—Pruritus—Fluorouracil—breast cancer	0.000163	0.000854	CcSEcCtD
Mepivacaine—Drowsiness—Doxorubicin—breast cancer	0.000162	0.000853	CcSEcCtD
Mepivacaine—Tachycardia—Docetaxel—breast cancer	0.000162	0.000851	CcSEcCtD
Mepivacaine—Oedema—Capecitabine—breast cancer	0.000161	0.000844	CcSEcCtD
Mepivacaine—Bradycardia—Epirubicin—breast cancer	0.00016	0.000842	CcSEcCtD
Mepivacaine—Dizziness—Irinotecan—breast cancer	0.000159	0.000834	CcSEcCtD
Mepivacaine—Shock—Capecitabine—breast cancer	0.000158	0.00083	CcSEcCtD
Mepivacaine—Tinnitus—Methotrexate—breast cancer	0.000157	0.000824	CcSEcCtD
Mepivacaine—Tachycardia—Capecitabine—breast cancer	0.000157	0.000823	CcSEcCtD
Mepivacaine—Sweating—Doxorubicin—breast cancer	0.000156	0.000818	CcSEcCtD
Mepivacaine—Urticaria—Paclitaxel—breast cancer	0.000155	0.000817	CcSEcCtD
Mepivacaine—Hyperhidrosis—Capecitabine—breast cancer	0.000155	0.000816	CcSEcCtD
Mepivacaine—Hypotension—Docetaxel—breast cancer	0.000155	0.000814	CcSEcCtD
Mepivacaine—Body temperature increased—Paclitaxel—breast cancer	0.000155	0.000813	CcSEcCtD
Mepivacaine—SCN9A—lymph node—breast cancer	0.000154	0.0392	CbGeAlD
Mepivacaine—Vomiting—Irinotecan—breast cancer	0.000153	0.000802	CcSEcCtD
Mepivacaine—Vomiting—Mitoxantrone—breast cancer	0.000153	0.000802	CcSEcCtD
Mepivacaine—Dizziness—Fluorouracil—breast cancer	0.000152	0.000798	CcSEcCtD
Mepivacaine—Chills—Methotrexate—breast cancer	0.000151	0.000793	CcSEcCtD
Mepivacaine—Headache—Mitoxantrone—breast cancer	0.00015	0.00079	CcSEcCtD
Mepivacaine—Headache—Irinotecan—breast cancer	0.00015	0.00079	CcSEcCtD
Mepivacaine—Hypotension—Capecitabine—breast cancer	0.00015	0.000788	CcSEcCtD
Mepivacaine—Lidocaine—CYP3A4—breast cancer	0.000149	0.0163	CrCbGaD
Mepivacaine—Paraesthesia—Docetaxel—breast cancer	0.000149	0.000783	CcSEcCtD
Mepivacaine—Vomiting—Gemcitabine—breast cancer	0.000149	0.000781	CcSEcCtD
Mepivacaine—Bradycardia—Doxorubicin—breast cancer	0.000148	0.000779	CcSEcCtD
Mepivacaine—Somnolence—Docetaxel—breast cancer	0.000147	0.000775	CcSEcCtD
Mepivacaine—Tinnitus—Epirubicin—breast cancer	0.000147	0.000771	CcSEcCtD
Mepivacaine—Erythema—Methotrexate—breast cancer	0.000146	0.00077	CcSEcCtD
Mepivacaine—Headache—Gemcitabine—breast cancer	0.000146	0.000769	CcSEcCtD
Mepivacaine—Vomiting—Fluorouracil—breast cancer	0.000146	0.000768	CcSEcCtD
Mepivacaine—Paraesthesia—Capecitabine—breast cancer	0.000144	0.000758	CcSEcCtD
Mepivacaine—Hypersensitivity—Paclitaxel—breast cancer	0.000144	0.000758	CcSEcCtD
Mepivacaine—Headache—Fluorouracil—breast cancer	0.000144	0.000756	CcSEcCtD
Mepivacaine—Nausea—Mitoxantrone—breast cancer	0.000143	0.000749	CcSEcCtD
Mepivacaine—Nausea—Irinotecan—breast cancer	0.000143	0.000749	CcSEcCtD
Mepivacaine—Back pain—Methotrexate—breast cancer	0.000142	0.000744	CcSEcCtD
Mepivacaine—Chills—Epirubicin—breast cancer	0.000141	0.000742	CcSEcCtD
Mepivacaine—Asthenia—Paclitaxel—breast cancer	0.00014	0.000738	CcSEcCtD
Mepivacaine—Nausea—Gemcitabine—breast cancer	0.000139	0.000729	CcSEcCtD
Mepivacaine—Pruritus—Paclitaxel—breast cancer	0.000138	0.000727	CcSEcCtD
Mepivacaine—Vision blurred—Methotrexate—breast cancer	0.000138	0.000725	CcSEcCtD
Mepivacaine—Erythema—Epirubicin—breast cancer	0.000137	0.00072	CcSEcCtD
Mepivacaine—Nausea—Fluorouracil—breast cancer	0.000136	0.000717	CcSEcCtD
Mepivacaine—Tinnitus—Doxorubicin—breast cancer	0.000136	0.000714	CcSEcCtD
Mepivacaine—Tension—Epirubicin—breast cancer	0.000135	0.000707	CcSEcCtD
Mepivacaine—Nervousness—Epirubicin—breast cancer	0.000133	0.0007	CcSEcCtD
Mepivacaine—Back pain—Epirubicin—breast cancer	0.000133	0.000697	CcSEcCtD
Mepivacaine—Body temperature increased—Docetaxel—breast cancer	0.000131	0.000689	CcSEcCtD
Mepivacaine—Chills—Doxorubicin—breast cancer	0.000131	0.000687	CcSEcCtD
Mepivacaine—Dizziness—Paclitaxel—breast cancer	0.000129	0.00068	CcSEcCtD
Mepivacaine—Vision blurred—Epirubicin—breast cancer	0.000129	0.000679	CcSEcCtD
Mepivacaine—Urticaria—Capecitabine—breast cancer	0.000128	0.00067	CcSEcCtD
Mepivacaine—Body temperature increased—Capecitabine—breast cancer	0.000127	0.000667	CcSEcCtD
Mepivacaine—Convulsion—Methotrexate—breast cancer	0.000127	0.000667	CcSEcCtD
Mepivacaine—Erythema—Doxorubicin—breast cancer	0.000127	0.000666	CcSEcCtD
Mepivacaine—Agitation—Epirubicin—breast cancer	0.000126	0.000662	CcSEcCtD
Mepivacaine—Tension—Doxorubicin—breast cancer	0.000124	0.000654	CcSEcCtD
Mepivacaine—Vomiting—Paclitaxel—breast cancer	0.000124	0.000654	CcSEcCtD
Mepivacaine—Lidocaine—ABCB1—breast cancer	0.000124	0.0136	CrCbGaD
Mepivacaine—Nervousness—Doxorubicin—breast cancer	0.000123	0.000647	CcSEcCtD
Mepivacaine—Syncope—Epirubicin—breast cancer	0.000123	0.000646	CcSEcCtD
Mepivacaine—Back pain—Doxorubicin—breast cancer	0.000123	0.000645	CcSEcCtD
Mepivacaine—Headache—Paclitaxel—breast cancer	0.000123	0.000644	CcSEcCtD
Mepivacaine—Hypersensitivity—Docetaxel—breast cancer	0.000122	0.000642	CcSEcCtD
Mepivacaine—Loss of consciousness—Epirubicin—breast cancer	0.00012	0.000633	CcSEcCtD
Mepivacaine—Anaphylactic shock—Methotrexate—breast cancer	0.00012	0.000628	CcSEcCtD
Mepivacaine—Vision blurred—Doxorubicin—breast cancer	0.00012	0.000628	CcSEcCtD
Mepivacaine—Asthenia—Docetaxel—breast cancer	0.000119	0.000625	CcSEcCtD
Mepivacaine—Convulsion—Epirubicin—breast cancer	0.000119	0.000624	CcSEcCtD
Mepivacaine—Hypertension—Epirubicin—breast cancer	0.000118	0.000622	CcSEcCtD
Mepivacaine—Hypersensitivity—Capecitabine—breast cancer	0.000118	0.000622	CcSEcCtD
Mepivacaine—SCN10A—lymph node—breast cancer	0.000117	0.0299	CbGeAlD
Mepivacaine—Pruritus—Docetaxel—breast cancer	0.000117	0.000617	CcSEcCtD
Mepivacaine—Agitation—Doxorubicin—breast cancer	0.000117	0.000612	CcSEcCtD
Mepivacaine—Anxiety—Epirubicin—breast cancer	0.000116	0.000611	CcSEcCtD
Mepivacaine—Nausea—Paclitaxel—breast cancer	0.000116	0.000611	CcSEcCtD
Mepivacaine—Hyperhidrosis—Methotrexate—breast cancer	0.000116	0.000607	CcSEcCtD
Mepivacaine—Asthenia—Capecitabine—breast cancer	0.000115	0.000605	CcSEcCtD
Mepivacaine—Syncope—Doxorubicin—breast cancer	0.000114	0.000598	CcSEcCtD
Mepivacaine—Pruritus—Capecitabine—breast cancer	0.000114	0.000597	CcSEcCtD
Mepivacaine—Oedema—Epirubicin—breast cancer	0.000112	0.000588	CcSEcCtD
Mepivacaine—Anaphylactic shock—Epirubicin—breast cancer	0.000112	0.000588	CcSEcCtD
Mepivacaine—Hypotension—Methotrexate—breast cancer	0.000112	0.000587	CcSEcCtD
Mepivacaine—Loss of consciousness—Doxorubicin—breast cancer	0.000111	0.000586	CcSEcCtD
Mepivacaine—Shock—Epirubicin—breast cancer	0.00011	0.000578	CcSEcCtD
Mepivacaine—Convulsion—Doxorubicin—breast cancer	0.00011	0.000577	CcSEcCtD
Mepivacaine—Dizziness—Docetaxel—breast cancer	0.00011	0.000576	CcSEcCtD
Mepivacaine—Hypertension—Doxorubicin—breast cancer	0.000109	0.000575	CcSEcCtD
Mepivacaine—Tachycardia—Epirubicin—breast cancer	0.000109	0.000574	CcSEcCtD
Mepivacaine—Hyperhidrosis—Epirubicin—breast cancer	0.000108	0.000568	CcSEcCtD
Mepivacaine—Anxiety—Doxorubicin—breast cancer	0.000108	0.000565	CcSEcCtD
Mepivacaine—Paraesthesia—Methotrexate—breast cancer	0.000107	0.000564	CcSEcCtD
Mepivacaine—SCN3A—lymph node—breast cancer	0.000107	0.0272	CbGeAlD
Mepivacaine—Somnolence—Methotrexate—breast cancer	0.000106	0.000558	CcSEcCtD
Mepivacaine—Dizziness—Capecitabine—breast cancer	0.000106	0.000558	CcSEcCtD
Mepivacaine—Vomiting—Docetaxel—breast cancer	0.000105	0.000554	CcSEcCtD
Mepivacaine—Hypotension—Epirubicin—breast cancer	0.000105	0.000549	CcSEcCtD
Mepivacaine—Headache—Docetaxel—breast cancer	0.000104	0.000546	CcSEcCtD
Mepivacaine—Anaphylactic shock—Doxorubicin—breast cancer	0.000104	0.000544	CcSEcCtD
Mepivacaine—Oedema—Doxorubicin—breast cancer	0.000104	0.000544	CcSEcCtD
Mepivacaine—Vomiting—Capecitabine—breast cancer	0.000102	0.000536	CcSEcCtD
Mepivacaine—Shock—Doxorubicin—breast cancer	0.000102	0.000535	CcSEcCtD
Mepivacaine—Tachycardia—Doxorubicin—breast cancer	0.000101	0.000531	CcSEcCtD
Mepivacaine—Headache—Capecitabine—breast cancer	0.000101	0.000529	CcSEcCtD
Mepivacaine—Paraesthesia—Epirubicin—breast cancer	0.0001	0.000528	CcSEcCtD
Mepivacaine—Hyperhidrosis—Doxorubicin—breast cancer	0.0001	0.000526	CcSEcCtD
Mepivacaine—Somnolence—Epirubicin—breast cancer	9.95e-05	0.000523	CcSEcCtD
Mepivacaine—Nausea—Docetaxel—breast cancer	9.85e-05	0.000518	CcSEcCtD
Mepivacaine—Hypotension—Doxorubicin—breast cancer	9.67e-05	0.000508	CcSEcCtD
Mepivacaine—Nausea—Capecitabine—breast cancer	9.54e-05	0.000501	CcSEcCtD
Mepivacaine—Urticaria—Methotrexate—breast cancer	9.5e-05	0.000499	CcSEcCtD
Mepivacaine—Body temperature increased—Methotrexate—breast cancer	9.45e-05	0.000497	CcSEcCtD
Mepivacaine—Paraesthesia—Doxorubicin—breast cancer	9.29e-05	0.000488	CcSEcCtD
Mepivacaine—Somnolence—Doxorubicin—breast cancer	9.2e-05	0.000484	CcSEcCtD
Mepivacaine—Urticaria—Epirubicin—breast cancer	8.89e-05	0.000467	CcSEcCtD
Mepivacaine—Body temperature increased—Epirubicin—breast cancer	8.84e-05	0.000465	CcSEcCtD
Mepivacaine—Hypersensitivity—Methotrexate—breast cancer	8.81e-05	0.000463	CcSEcCtD
Mepivacaine—Asthenia—Methotrexate—breast cancer	8.58e-05	0.000451	CcSEcCtD
Mepivacaine—Pruritus—Methotrexate—breast cancer	8.46e-05	0.000444	CcSEcCtD
Mepivacaine—Hypersensitivity—Epirubicin—breast cancer	8.24e-05	0.000433	CcSEcCtD
Mepivacaine—Urticaria—Doxorubicin—breast cancer	8.22e-05	0.000432	CcSEcCtD
Mepivacaine—Body temperature increased—Doxorubicin—breast cancer	8.18e-05	0.00043	CcSEcCtD
Mepivacaine—Asthenia—Epirubicin—breast cancer	8.03e-05	0.000422	CcSEcCtD
Mepivacaine—Pruritus—Epirubicin—breast cancer	7.91e-05	0.000416	CcSEcCtD
Mepivacaine—Dizziness—Methotrexate—breast cancer	7.9e-05	0.000415	CcSEcCtD
Mepivacaine—Hypersensitivity—Doxorubicin—breast cancer	7.63e-05	0.000401	CcSEcCtD
Mepivacaine—Vomiting—Methotrexate—breast cancer	7.6e-05	0.000399	CcSEcCtD
Mepivacaine—Headache—Methotrexate—breast cancer	7.49e-05	0.000393	CcSEcCtD
Mepivacaine—Asthenia—Doxorubicin—breast cancer	7.43e-05	0.00039	CcSEcCtD
Mepivacaine—Dizziness—Epirubicin—breast cancer	7.4e-05	0.000389	CcSEcCtD
Mepivacaine—Pruritus—Doxorubicin—breast cancer	7.32e-05	0.000385	CcSEcCtD
Mepivacaine—Vomiting—Epirubicin—breast cancer	7.11e-05	0.000374	CcSEcCtD
Mepivacaine—Nausea—Methotrexate—breast cancer	7.1e-05	0.000373	CcSEcCtD
Mepivacaine—Headache—Epirubicin—breast cancer	7.01e-05	0.000368	CcSEcCtD
Mepivacaine—Dizziness—Doxorubicin—breast cancer	6.84e-05	0.00036	CcSEcCtD
Mepivacaine—Nausea—Epirubicin—breast cancer	6.64e-05	0.000349	CcSEcCtD
Mepivacaine—Vomiting—Doxorubicin—breast cancer	6.58e-05	0.000346	CcSEcCtD
Mepivacaine—Headache—Doxorubicin—breast cancer	6.48e-05	0.000341	CcSEcCtD
Mepivacaine—Nausea—Doxorubicin—breast cancer	6.15e-05	0.000323	CcSEcCtD
Mepivacaine—SCN5A—Axon guidance—FGFR1—breast cancer	5.55e-05	0.000397	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—NCOA1—breast cancer	5.53e-05	0.000395	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—ERBB2—breast cancer	5.52e-05	0.000395	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—ERBB2—breast cancer	5.52e-05	0.000395	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—KDR—breast cancer	5.51e-05	0.000394	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—KDR—breast cancer	5.51e-05	0.000394	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—ADAM10—breast cancer	5.45e-05	0.00039	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—LEP—breast cancer	5.42e-05	0.000388	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—LEP—breast cancer	5.42e-05	0.000388	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—MAPK3—breast cancer	5.41e-05	0.000387	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—NOTCH1—breast cancer	5.4e-05	0.000386	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—MET—breast cancer	5.39e-05	0.000386	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—CDK4—breast cancer	5.39e-05	0.000386	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—MET—breast cancer	5.39e-05	0.000386	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—CDK4—breast cancer	5.39e-05	0.000386	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—RAF1—breast cancer	5.38e-05	0.000385	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—RAF1—breast cancer	5.38e-05	0.000385	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—RAF1—breast cancer	5.36e-05	0.000383	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—RELA—breast cancer	5.33e-05	0.000382	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—ERBB2—breast cancer	5.32e-05	0.000381	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—ERBB2—breast cancer	5.32e-05	0.000381	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—KDR—breast cancer	5.31e-05	0.00038	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—KDR—breast cancer	5.31e-05	0.00038	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—ERBB2—breast cancer	5.3e-05	0.000379	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—FGF10—breast cancer	5.3e-05	0.000379	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—KDR—breast cancer	5.23e-05	0.000374	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—CDK4—breast cancer	5.2e-05	0.000372	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—CDK4—breast cancer	5.2e-05	0.000372	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—MET—breast cancer	5.2e-05	0.000372	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—MET—breast cancer	5.2e-05	0.000372	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—NOTCH1—breast cancer	5.19e-05	0.000371	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—NOTCH1—breast cancer	5.19e-05	0.000371	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—VEGFA—breast cancer	5.17e-05	0.00037	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—MMP9—breast cancer	5.15e-05	0.000369	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—EGFR—breast cancer	5.15e-05	0.000368	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—MET—breast cancer	5.12e-05	0.000366	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—AKT2—breast cancer	5.05e-05	0.000361	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—NOTCH1—breast cancer	5e-05	0.000358	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—NOTCH1—breast cancer	5e-05	0.000358	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—MMP9—breast cancer	4.93e-05	0.000353	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—ABL1—breast cancer	4.93e-05	0.000352	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—MMP2—breast cancer	4.89e-05	0.00035	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—KRAS—breast cancer	4.86e-05	0.000348	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—AKT2—breast cancer	4.83e-05	0.000346	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—SMAD4—breast cancer	4.77e-05	0.000341	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—SRC—breast cancer	4.75e-05	0.00034	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—MMP9—breast cancer	4.73e-05	0.000339	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—MMP9—breast cancer	4.73e-05	0.000339	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—MMP2—breast cancer	4.68e-05	0.000335	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—HES1—breast cancer	4.66e-05	0.000333	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—AKT2—breast cancer	4.64e-05	0.000332	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—AKT2—breast cancer	4.64e-05	0.000332	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—CTNNB1—breast cancer	4.64e-05	0.000332	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—NCOR1—breast cancer	4.63e-05	0.000331	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—VEGFA—breast cancer	4.63e-05	0.000331	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—MMP9—breast cancer	4.57e-05	0.000327	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—MMP9—breast cancer	4.57e-05	0.000327	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—MMP9—breast cancer	4.55e-05	0.000325	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—SRC—breast cancer	4.54e-05	0.000325	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—MMP2—breast cancer	4.5e-05	0.000322	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—MMP2—breast cancer	4.5e-05	0.000322	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—AKT2—breast cancer	4.48e-05	0.00032	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—AKT2—breast cancer	4.48e-05	0.00032	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—TNF—breast cancer	4.43e-05	0.000317	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—VEGFA—breast cancer	4.43e-05	0.000317	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—MAPK3—breast cancer	4.38e-05	0.000313	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—SRC—breast cancer	4.37e-05	0.000312	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—SRC—breast cancer	4.37e-05	0.000312	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—MMP2—breast cancer	4.33e-05	0.00031	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—MMP2—breast cancer	4.33e-05	0.00031	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—RAF1—breast cancer	4.33e-05	0.00031	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—RELA—breast cancer	4.31e-05	0.000309	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—ERBB2—breast cancer	4.29e-05	0.000307	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—MMP2—breast cancer	4.27e-05	0.000306	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—VEGFA—breast cancer	4.25e-05	0.000304	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—VEGFA—breast cancer	4.25e-05	0.000304	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—SRC—breast cancer	4.21e-05	0.000301	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—SRC—breast cancer	4.21e-05	0.000301	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—SRC—breast cancer	4.19e-05	0.0003	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—MAPK3—breast cancer	4.19e-05	0.0003	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—EGFR—breast cancer	4.16e-05	0.000298	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—RAF1—breast cancer	4.14e-05	0.000297	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—HRAS—breast cancer	4.13e-05	0.000296	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—RELA—breast cancer	4.13e-05	0.000295	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—ERBB2—breast cancer	4.1e-05	0.000293	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—VEGFA—breast cancer	4.1e-05	0.000293	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—VEGFA—breast cancer	4.1e-05	0.000293	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—VEGFA—breast cancer	4.08e-05	0.000292	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—STAT3—breast cancer	4.04e-05	0.000289	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—MAPK3—breast cancer	4.02e-05	0.000288	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—MAPK3—breast cancer	4.02e-05	0.000288	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—EGFR—breast cancer	3.98e-05	0.000285	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—RAF1—breast cancer	3.98e-05	0.000285	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—RAF1—breast cancer	3.98e-05	0.000285	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—RELA—breast cancer	3.96e-05	0.000284	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—RELA—breast cancer	3.96e-05	0.000284	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—FGFR1—breast cancer	3.96e-05	0.000284	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—IL6—breast cancer	3.96e-05	0.000283	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—ERBB2—breast cancer	3.94e-05	0.000282	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—ERBB2—breast cancer	3.94e-05	0.000282	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—KRAS—breast cancer	3.93e-05	0.000281	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—MAPK3—breast cancer	3.88e-05	0.000278	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—MAPK3—breast cancer	3.88e-05	0.000278	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—MAPK3—breast cancer	3.86e-05	0.000276	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—RAF1—breast cancer	3.84e-05	0.000275	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—RAF1—breast cancer	3.84e-05	0.000275	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—EGFR—breast cancer	3.83e-05	0.000274	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—EGFR—breast cancer	3.83e-05	0.000274	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—RELA—breast cancer	3.82e-05	0.000274	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—RELA—breast cancer	3.82e-05	0.000274	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—LEP—breast cancer	3.81e-05	0.000273	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—ERBB2—breast cancer	3.8e-05	0.000272	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—ERBB2—breast cancer	3.8e-05	0.000272	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—RAF1—breast cancer	3.78e-05	0.000271	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—KRAS—breast cancer	3.76e-05	0.000269	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—CTNNB1—breast cancer	3.75e-05	0.000268	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—TGFB1—breast cancer	3.75e-05	0.000268	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—ERBB2—breast cancer	3.74e-05	0.000268	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—KDR—breast cancer	3.73e-05	0.000267	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—EGFR—breast cancer	3.69e-05	0.000264	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—EGFR—breast cancer	3.69e-05	0.000264	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—MMP9—breast cancer	3.68e-05	0.000263	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—EGFR—breast cancer	3.67e-05	0.000263	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—MET—breast cancer	3.65e-05	0.000261	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—CDK4—breast cancer	3.65e-05	0.000261	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—KRAS—breast cancer	3.61e-05	0.000259	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—KRAS—breast cancer	3.61e-05	0.000259	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—CTNNB1—breast cancer	3.59e-05	0.000257	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—IL6—breast cancer	3.58e-05	0.000256	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—NOTCH1—breast cancer	3.52e-05	0.000252	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—MMP9—breast cancer	3.52e-05	0.000252	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—TNF—breast cancer	3.5e-05	0.00025	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—KRAS—breast cancer	3.49e-05	0.000249	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—KRAS—breast cancer	3.49e-05	0.000249	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—KRAS—breast cancer	3.47e-05	0.000248	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—CTNNB1—breast cancer	3.45e-05	0.000247	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—CTNNB1—breast cancer	3.45e-05	0.000247	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—SRC—breast cancer	3.39e-05	0.000243	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—MMP9—breast cancer	3.38e-05	0.000242	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—MMP9—breast cancer	3.38e-05	0.000242	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—HRAS—breast cancer	3.34e-05	0.000239	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—CTNNB1—breast cancer	3.32e-05	0.000238	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—CTNNB1—breast cancer	3.32e-05	0.000238	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—VEGFA—breast cancer	3.3e-05	0.000236	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—STAT3—breast cancer	3.27e-05	0.000234	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—MMP9—breast cancer	3.26e-05	0.000233	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—MMP9—breast cancer	3.26e-05	0.000233	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—SRC—breast cancer	3.24e-05	0.000232	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—MMP9—breast cancer	3.21e-05	0.00023	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—IL6—breast cancer	3.2e-05	0.000229	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—HRAS—breast cancer	3.2e-05	0.000229	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—VEGFA—breast cancer	3.16e-05	0.000226	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—AKT2—breast cancer	3.15e-05	0.000225	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—STAT3—breast cancer	3.13e-05	0.000224	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—MAPK3—breast cancer	3.12e-05	0.000223	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—SRC—breast cancer	3.12e-05	0.000223	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—SRC—breast cancer	3.12e-05	0.000223	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—HRAS—breast cancer	3.07e-05	0.00022	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—HRAS—breast cancer	3.07e-05	0.00022	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—IL6—breast cancer	3.06e-05	0.000219	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—MMP2—breast cancer	3.05e-05	0.000218	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—VEGFA—breast cancer	3.03e-05	0.000217	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—VEGFA—breast cancer	3.03e-05	0.000217	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—TGFB1—breast cancer	3.03e-05	0.000217	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—STAT3—breast cancer	3e-05	0.000215	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—STAT3—breast cancer	3e-05	0.000215	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—SRC—breast cancer	3e-05	0.000215	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—SRC—breast cancer	3e-05	0.000215	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—MAPK3—breast cancer	2.99e-05	0.000214	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—EGFR—breast cancer	2.97e-05	0.000213	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—HRAS—breast cancer	2.96e-05	0.000212	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—HRAS—breast cancer	2.96e-05	0.000212	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—SRC—breast cancer	2.96e-05	0.000212	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—HRAS—breast cancer	2.95e-05	0.000211	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—IL6—breast cancer	2.94e-05	0.00021	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—IL6—breast cancer	2.94e-05	0.00021	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—VEGFA—breast cancer	2.93e-05	0.000209	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—VEGFA—breast cancer	2.93e-05	0.000209	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—TGFB1—breast cancer	2.9e-05	0.000207	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—STAT3—breast cancer	2.9e-05	0.000207	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—STAT3—breast cancer	2.9e-05	0.000207	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—VEGFA—breast cancer	2.88e-05	0.000206	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—MAPK3—breast cancer	2.87e-05	0.000205	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—MAPK3—breast cancer	2.87e-05	0.000205	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—EGFR—breast cancer	2.84e-05	0.000203	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—IL6—breast cancer	2.84e-05	0.000203	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—IL6—breast cancer	2.84e-05	0.000203	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—TNF—breast cancer	2.83e-05	0.000202	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—IL6—breast cancer	2.82e-05	0.000202	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—KRAS—breast cancer	2.81e-05	0.000201	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—TGFB1—breast cancer	2.78e-05	0.000199	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—TGFB1—breast cancer	2.78e-05	0.000199	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—MAPK3—breast cancer	2.77e-05	0.000198	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—MAPK3—breast cancer	2.77e-05	0.000198	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—EGFR—breast cancer	2.73e-05	0.000195	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—EGFR—breast cancer	2.73e-05	0.000195	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—MAPK3—breast cancer	2.73e-05	0.000195	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—TNF—breast cancer	2.71e-05	0.000194	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—RAF1—breast cancer	2.7e-05	0.000193	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—RELA—breast cancer	2.69e-05	0.000192	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—TGFB1—breast cancer	2.69e-05	0.000192	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—TGFB1—breast cancer	2.69e-05	0.000192	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—KRAS—breast cancer	2.68e-05	0.000192	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—ERBB2—breast cancer	2.67e-05	0.000191	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—EGFR—breast cancer	2.63e-05	0.000188	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—EGFR—breast cancer	2.63e-05	0.000188	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—AKT1—breast cancer	2.6e-05	0.000186	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—TNF—breast cancer	2.6e-05	0.000186	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—TNF—breast cancer	2.6e-05	0.000186	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—EGFR—breast cancer	2.59e-05	0.000186	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—KRAS—breast cancer	2.58e-05	0.000185	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—KRAS—breast cancer	2.58e-05	0.000185	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—TNF—breast cancer	2.51e-05	0.000179	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—TNF—breast cancer	2.51e-05	0.000179	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—KRAS—breast cancer	2.49e-05	0.000178	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—KRAS—breast cancer	2.49e-05	0.000178	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—KRAS—breast cancer	2.45e-05	0.000175	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—HRAS—breast cancer	2.39e-05	0.000171	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—CTNNB1—breast cancer	2.34e-05	0.000167	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—MMP9—breast cancer	2.29e-05	0.000164	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—IL6—breast cancer	2.28e-05	0.000163	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—HRAS—breast cancer	2.28e-05	0.000163	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—HRAS—breast cancer	2.19e-05	0.000157	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—HRAS—breast cancer	2.19e-05	0.000157	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—IL6—breast cancer	2.18e-05	0.000156	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—HRAS—breast cancer	2.11e-05	0.000151	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—HRAS—breast cancer	2.11e-05	0.000151	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—SRC—breast cancer	2.11e-05	0.000151	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—AKT1—breast cancer	2.11e-05	0.000151	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—IL6—breast cancer	2.1e-05	0.00015	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—IL6—breast cancer	2.1e-05	0.00015	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—HRAS—breast cancer	2.08e-05	0.000149	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—VEGFA—breast cancer	2.06e-05	0.000147	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—STAT3—breast cancer	2.04e-05	0.000146	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—IL6—breast cancer	2.02e-05	0.000145	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—IL6—breast cancer	2.02e-05	0.000145	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—AKT1—breast cancer	2.01e-05	0.000144	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—IL6—breast cancer	1.99e-05	0.000143	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—MAPK3—breast cancer	1.95e-05	0.000139	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—AKT1—breast cancer	1.94e-05	0.000139	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—AKT1—breast cancer	1.94e-05	0.000139	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—TGFB1—breast cancer	1.89e-05	0.000135	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—AKT1—breast cancer	1.87e-05	0.000134	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—AKT1—breast cancer	1.87e-05	0.000134	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—EGFR—breast cancer	1.85e-05	0.000132	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—TNF—breast cancer	1.76e-05	0.000126	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—KRAS—breast cancer	1.75e-05	0.000125	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—HRAS—breast cancer	1.49e-05	0.000106	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—IL6—breast cancer	1.42e-05	0.000102	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—AKT1—breast cancer	1.31e-05	9.39e-05	CbGpPWpGaD
